The Next Big Breakout Stock

Shares of Arrowhead Research Corp. ARWR are trading higher on the session by 1.92%, at $0.53. The name has been consolidating above $0.50 for the past week following a spike higher, where ARWR touched $0.69. The 20-day moving average has begun to tick higher and higher; a 20/50 upside cross should occur within a few days. This will add bullish support to an already spring-loaded chart. Arrowhead Research also just appointed Tim Triche to its scientific research advisory board; his is an oncology expert and will bolster the already stacked board. Note that fellow nano-tech stock, Altair Nanotechnologies ALTI has been under massive accumulation over the past few days, rallying over 100% during that time period. One further note: ARWR is technically a NASDAQ deficient user for not maintaining a price above $1.00. The company did get a six month extension on June 7th regarding the matter, so the risk of delistment over the short term is minimal at best. Arrowhead Research Corporation is a development-stage company. Arrowhead is a nanomedicine company engaged in development therapeutic products at the interface of biology and nano-engineering to cure disease and improve human health.